908 Devices (MASS) Financials: History & Chart

908 Devices Inc.(MASS)

Medical - Specialties · Burlington, MA

$12.43-0.37 (-2.89%)

Delayed quote: Oct 6, 2026, 1:59 PM EDT

About 908 Devices Inc.

908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company’s products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Burlington, Massachusetts.

Burlington, MA

172 employees

www.908devices.com

Healthcare / Medical - Specialties

Sector: Healthcare
Industry: Medical - Specialties
CEO: Kevin J. Knopp

View full financials

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Revenue	60.84M	16.07M	13.38M	17.38M	14.01M	13.04M	11.78M	18.82M	14.52M
Cost of Goods Sold	30.55M	7.73M	7.00M	8.71M	7.11M	6.66M	6.24M	9.65M	6.74M
Gross Profit	30.29M	8.34M	6.38M	8.67M	6.90M	6.37M	5.54M	9.17M	7.78M
Gross Profit Margin	49.8%	51.9%	47.7%	49.9%	49.3%	48.9%	47.0%	48.7%	53.6%
Total Operating Expenses	58.29M	21.15M	12.88M	11.84M	12.41M	21.53M	16.57M	29.43M	32.27M
Research & Development	13.16M	3.60M	3.06M	3.12M	3.38M	4.41M	3.83M	6.54M	4.21M
Selling, General & Administrative	38.68M	11.11M	9.82M	8.72M	9.04M	0.00	0.00	0.00	0.00
Operating Income (EBIT)	-27.99M	-12.81M	-6.50M	-3.17M	-5.52M	-15.16M	-11.03M	-20.25M	-24.49M
Operating Margin	-46.0%	-79.7%	-48.6%	-18.2%	-39.4%	-116.3%	-93.6%	-107.6%	-168.7%
Income Before Tax (EBT)	-34.47M	-11.95M	-11.96M	4.32M	-14.88M	-12.84M	-9.84M	-19.52M	-23.65M
Interest Income	3.06M	N/A	936K	1.02M	1.10M	1.20M	816K	753K	879K
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Other Income/Expense	-6.47M	861K	-5.45M	7.48M	-9.37M	2.32M	1.19M	736K	846K
Net Income	-34.48M	-11.89M	-11.96M	4.28M	-14.91M	-13.31M	43.60M	-19.45M	-29.30M
Income Tax Expense	-191K	-54K	0.00	-166K	29K	71K	0.00	-71K	0.00
Net Profit Margin	-56.7%	-74.0%	-89.3%	24.6%	-106.5%	-102.1%	370.2%	-103.3%	-201.8%
EBITDA	-23.29M	-11.45M	-5.36M	-2.05M	-4.42M	-14.19M	-9.73M	-18.82M	-23.08M
EBITDA Margin	-38.3%	-71.2%	-40.1%	-11.8%	-31.6%	-108.9%	-82.7%	-100.0%	-159.0%
Depreciation & Amortization	4.71M	1.36M	1.14M	1.12M	1.09M	972K	1.29M	1.44M	1.41M
EPS Basic	-0.93	-0.32	-0.32	0.12	-0.41	-0.37	1.23	-0.57	-0.68
EPS Diluted	-0.95	-0.32	-0.32	0.10	-0.41	-0.37	1.23	-0.57	-0.68
Weighted Average Basic Shares	37.73M	37.73M	36.82M	36.22M	36.10M	35.88M	35.39M	34.67M	34.67M
Weighted Average Diluted Shares	37.73M	37.73M	36.82M	38.92M	36.10M	35.88M	35.39M	34.67M	34.67M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	56.20M	59.63M	50.23M	46.85M	42.21M	26.89M	17.97M	22.05M
Cost of Goods Sold	29.40M	29.71M	24.91M	20.83M	18.97M	11.97M	9.83M	9.66M
Gross Profit	26.80M	29.93M	25.32M	26.02M	23.23M	14.92M	8.14M	12.39M
Gross Profit Margin	47.7%	50.2%	50.4%	55.5%	55.0%	55.5%	45.3%	56.2%
Total Operating Expenses	50.98M	106.64M	68.08M	61.41M	45.30M	20.74M	20.29M	18.83M
Research & Development	13.80M	25.50M	21.90M	17.53M	13.07M	8.23M	8.99M	9.53M
Selling, General & Administrative	37.18M	0.00	0.00	43.88M	32.23M	0.00	0.00	9.30M
Operating Income (EBIT)	-24.18M	-76.72M	-42.76M	-35.38M	-22.07M	-5.82M	-12.14M	-6.44M
Operating Margin	-43.0%	-128.7%	-85.1%	-75.5%	-52.3%	-21.6%	-67.6%	-29.2%
Income Before Tax (EBT)	-33.34M	-72.49M	-36.61M	-33.56M	-22.17M	-12.82M	-13.37M	-7.54M
Interest Income	4.14M	4.49M	6.48M	2.03M	548K	N/A	N/A	N/A
Interest Expense	N/A	N/A	201K	129K	486K	976K	1.53M	1.15M
Other Income/Expense	-9.16M	4.23M	6.15M	1.82M	-100K	-7.00M	-1.23M	-1.10M
Net Income	-36.64M	-72.21M	-36.40M	-33.56M	-22.17M	-12.82M	-13.37M	-7.54M
Income Tax Expense	-66K	-282K	-211K	0.00	0.00	0.00	0.00	50K
Net Profit Margin	-65.2%	-121.1%	-72.5%	-71.6%	-52.5%	-47.7%	-74.4%	-34.2%
EBITDA	-19.71M	-72.04M	-40.37M	-33.77M	-21.14M	-4.98M	-11.24M	-5.54M
EBITDA Margin	-35.1%	-120.8%	-80.4%	-72.1%	-50.1%	-18.5%	-62.6%	-25.1%
Depreciation & Amortization	4.46M	4.68M	2.38M	1.61M	925K	831K	900K	896K
EPS Basic	-1.01	-2.12	-1.13	-1.07	-0.79	-2.35	-2.02	-0.93
EPS Diluted	-0.94	-2.12	-1.13	-1.07	-0.79	-2.35	-2.02	-0.93
Weighted Average Basic Shares	36.22M	34.08M	32.21M	31.49M	27.96M	5.49M	7.53M	8.12M
Weighted Average Diluted Shares	38.92M	34.08M	32.24M	31.49M	27.96M	5.49M	7.53M	8.12M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.